Science Explorer Back to mapMap
Discussion
Topic · Immunology

Galectins and Cancer Biology

Galectins and Cancer Biology is a research topic within Immunology. Science Explorer counts 24k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers explores the diverse roles of galectins in immune regulation, inflammation, cancer, macrophage activation, T cell dysfunction, fibrosis, angiogenesis, heart failure, and autoimmunity. Galectins are implicated in modulating various aspects of immune responses and have potential implications for therapeutic interventions in a range of diseases.

  • Galectins
  • Immune Regulation
  • Inflammation
  • Cancer
  • Macrophage Activation
  • T Cell Dysfunction
  • Fibrosis
  • Angiogenesis
  • Heart Failure
  • Autoimmunity
Research works
24k
fractional, since 1950
In the world top 10%
2.4k
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+1%
the tick is no change
Largest producer
China
44% of the 10 largest, 2022-now
Galectins and Cancer Biology

Which countries lead Galectins and Cancer Biology research?

By volume, China and the United States publish the most (1.2k and 628 works in 2022-now).

By volume, 2022-now

  1. 1 China 1.2k works
  2. 2 United States 628 works
  3. 3 Japan 192 works
  4. 4 Germany 127 works
  5. 5 India 112 works
  6. 6 Italy 101 works
  7. 7 France 90 works
  8. 8 United Kingdom 87 works
  9. 9 Türkiye 80 works
  10. 10 South Korea 73 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

China: 44.2%United States: 23.5%Japan: 7.2%Germany: 4.7%6 others listed: 20.4%44%largest
China1,177 · 44.2%United States628 · 23.5%Japan192 · 7.2%Germany127 · 4.7%6 others listed543 · 20.4%

Shares of the rows listed above, not of the whole node.

Which institutions lead Galectins and Cancer Biology research?

By volume in 2022-now, Harvard University publishes the most Galectins and Cancer Biology research, followed by Sun Yat-sen University and Shanghai Jiao Tong University.

By volume, 2022-now

  1. 1 Harvard UniversityUnited States 36 works
  2. 2 Sun Yat-sen UniversityChina 34 works
  3. 3 Shanghai Jiao Tong UniversityChina 31 works
  4. 4 Nanjing Medical UniversityChina 31 works
  5. 5 Fudan UniversityChina 24 works
  6. 6 Zhejiang UniversityChina 23 works
  7. 7 Peking UniversityChina 23 works
  8. 8 Centre National de la Recherche ScientifiqueFrance 22 works
  9. 9 Central South UniversityChina 22 works
  10. 10 Huazhong University of Science and TechnologyChina 20 works

Who are the leading researchers in Galectins and Cancer Biology?

The most-cited researchers publishing on Galectins and Cancer Biology include George Davey Smith, Mark J. Daly and Peer Bork.

  1. 1 George Davey Smith United Kingdom 435k citations
  2. 2 Mark J. Daly United States 403k citations
  3. 3 Peer Bork Germany 396k citations
  4. 4 Guido Kroemer France 386k citations
  5. 5 Bert Vogelstein United States 373k citations
  6. 6 Gad A. Getz United States 364k citations
  7. 7 John J.V. McMurray United Kingdom 349k citations
  8. 8 Hermann Brenner Germany 343k citations
  9. 9 Shizuo Akira Japan 342k citations
  10. 10 Jun Wang China 340k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Galectins and Cancer Biology?

The most cited paper in Galectins and Cancer Biology is "The complete genome sequence of the gastric pathogen Helicobacter pylori" (Jean-F. Tomb et al., 1997), with 3,570 citations. Next come "The pro- and anti-inflammatory properties of the cytokine interleukin-6" (3,248) and "Glycosylation in cancer: mechanisms and clinical implications" (3,210).

Most cited papers
#PaperReleasedCitations
1 The complete genome sequence of the gastric pathogen Helicobacter pylori Jean-F. Tomb et al. · Nature Open access 7 Aug 1997 3,570
2 The pro- and anti-inflammatory properties of the cytokine interleukin-6 Jürgen Scheller, Athena Chalaris, Dirk Schmidt‐Arras et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research Open access 5 Feb 2011 3,248
3 Glycosylation in cancer: mechanisms and clinical implications Salomé S. Pinho, Celso Albuquerque Reis · Nature reviews. Cancer ReviewOpen access 20 Aug 2015 3,210
4 Helicobacter pylori Infection Sebastian Suerbaum, Pierre Michetti · New England Journal of Medicine 9 Oct 2002 3,012
5 Pore-forming activity and structural autoinhibition of the gasdermin family Jingjin Ding, Kun Wang, Wang Liu et al. · Nature 7 Jun 2016 2,855
All 100 most cited papers, with filters and sorting

Where is Galectins and Cancer Biology research done?

The largest centres of Galectins and Cancer Biology research in 2022-now are Beijing (China), Shanghai (China), Guangzhou (China) and Nanjing (China).

Largest cities, 2022-now

  1. 1 BeijingChina 129 works
  2. 2 ShanghaiChina 97 works
  3. 3 GuangzhouChina 78 works
  4. 4 NanjingChina 54 works
  5. 5 WuhanChina 49 works
  6. 6 HangzhouChina 46 works
  7. 7 TokyoJapan 46 works
  8. 8 ParisFrance 41 works
  9. 9 MoscowRussia 34 works
  10. 10 JinanChina 33 works
See Galectins and Cancer Biology on the map

Where is the best place to study Galectins and Cancer Biology?

Among universities, judged by research, Harvard University, Sun Yat-sen University and Nanjing Medical University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%mean 16.54%fractional works in this field (log) →share of work in the world top 10% →Harvard UniversitySun Yat-sen UniversityZhejiang UniversityNanjing Medical Univ…
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 83.922.7%3.5×36 -11.4%
2Sun Yat-sen UniversityChina 73.520.5%5.1×34 +47.3%
3Nanjing Medical UniversityChina 61.910.3%10.8×31 +38.8%
4Zhejiang UniversityChina 61.817.7%2.7×23 +19.9%
5Fudan UniversityChina 60.415.6%4.8×24 +36.4%
6Johns Hopkins UniversityUnited States 59.623.7%2.6×13 -16.9%
7Nanchang UniversityChina 58.517.3%6.5×16 +100.6%
8Shanghai Jiao Tong UniversityChina 57.08.5%3.4×31 +22.2%
9Central South UniversityChina 56.113.5%3.5×22 +29.0%
10Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 55.515.6%5.4×18 +17.9%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Galectins and Cancer Biology, country by country

Is Galectins and Cancer Biology research growing?

Output in 2022-2025 was 1% higher than in 2018-2021, peaking in 2021. The fastest-growing topics are Galectins and Cancer Biology.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Galectins and Cancer Biology as a percentage of every work published that year, 0.016% in 2024.

still counting0.020%0.040%Galectins and Cancer Biology0.014% in 202519801990200020102020

Fractional works of Galectins and Cancer Biology over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Galectins and Cancer Biology10.1% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Galectins and Cancer Biology. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.